DiaMedica Therapeutics Inc (DMAC)
3.17
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
3.18
+0.01
(+0.32%)
After-Hours: 20:00
DiaMedica Therapeutics Free Cash Flow: -20.32M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -20.32M |
December 31, 2023 | -18.75M |
September 30, 2023 | -17.74M |
June 30, 2023 | -15.33M |
March 31, 2023 | -12.80M |
December 31, 2022 | -11.59M |
September 30, 2022 | -11.60M |
June 30, 2022 | -12.25M |
March 31, 2022 | -11.84M |
December 31, 2021 | -12.27M |
September 30, 2021 | -12.52M |
June 30, 2021 | -11.82M |
March 31, 2021 | -10.57M |
December 31, 2020 | -9.232M |
September 30, 2020 | -8.036M |
June 30, 2020 | -6.921M |
March 31, 2020 | -8.948M |
December 31, 2019 | -9.102M |
September 30, 2019 | -9.124M |
June 30, 2019 | -9.751M |
March 31, 2019 | -7.913M |
December 31, 2018 | -5.746M |
September 30, 2018 | -4.849M |
June 30, 2018 | -3.673M |
March 31, 2018 | -4.066M |
Date | Value |
---|---|
December 31, 2017 | -3.922M |
September 30, 2017 | -4.203M |
June 30, 2017 | -4.452M |
March 31, 2017 | -3.423M |
December 31, 2016 | -2.994M |
September 30, 2016 | -2.266M |
June 30, 2016 | -1.518M |
March 31, 2016 | -1.620M |
December 31, 2015 | -1.567M |
September 30, 2015 | -1.146M |
June 30, 2015 | -3.428M |
March 31, 2015 | -2.971M |
December 31, 2014 | -3.787M |
September 30, 2014 | -4.144M |
June 30, 2014 | -2.838M |
March 31, 2014 | -4.892M |
December 31, 2013 | -5.637M |
September 30, 2013 | -6.617M |
June 30, 2013 | -7.426M |
March 31, 2013 | -6.760M |
December 31, 2012 | -5.547M |
September 30, 2012 | -5.386M |
June 30, 2012 | -4.257M |
March 31, 2012 | -3.540M |
December 31, 2011 | -3.515M |
Free Cash Flow Range, Past 5 Years
-20.32M
Minimum
Mar 2024
-6.921M
Maximum
Jun 2020
-12.03M
Average
-11.71M
Median
Free Cash Flow Benchmarks
NextCure Inc | -51.41M |
NovaBay Pharmaceuticals Inc | -4.524M |
Palatin Technologies Inc | -33.83M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -18.27M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -6.653M |
Cash from Investing (Quarterly) | 4.208M |
Cash from Financing (Quarterly) | -0.001M |
Free Cash Flow Per Share (Quarterly) | -0.1755 |
Free Cash Flow Yield | -18.15% |